London stocks slip as BoE slows bond purchases; AstraZeneca weighs
Reuters
Published Jun 18, 2020 08:29
Updated Jun 18, 2020 17:00
By Susan Mathew
(Reuters) - UK shares fell on Thursday after the Bank of England's slowed the pace of its huge bond-buying programme, while a surge in coronavirus cases in the United States and China fanned fears of a second wave of infections.
The blue-chip FTSE 100 (FTSE) was down 0.5% following its strongest two-day percentage gain in two weeks on Wednesday.
The BoE said it saw signs that the British economy was recovering from a pandemic-induced slump. It raised its asset purchase target by 100 billion pounds, as expected, but disappointed markets as it said the increase should see it through to the end of the year.
"The risk (for asset purchases) was skewed to the upside," said Stefan Koopman, senior market economist at Rabobank.
"In light of these expectations, the (bank's) decision actually turned out a bit hawkish," he said, adding that Rabobank still sees a further increase beyond August.
AstraZeneca (L:AZN) weighed the most, down 2.2%. The European Commission is in advanced deal talks with Johnson & Johnson (N:JNJ) on its COVID-19 vaccine under development, sources told Reuters.
Last week, many euro zone countries said they had acquired 400 million potential vaccine doses from the British drugmaker for its potential COVID-19 shot.
The mid-cap FTSE 250 (FTMC) fell 0.4%, with real estate (FTUB8600), consumer stocks (FTNMX3530) (FTNMX3570) and mining and metal (FTNMX1770) (FTNMX1750) stocks leading declines.
The commodity-heavy FTSE 100 has rebounded more than 25% from a coronavirus-driven crash in March, but the index has still lagged both European and U.S. stock markets amid forecasts of the worst UK recession in three centuries.
Among individual stocks, homebuilder Taylor Wimpey (L:TW) tumbled 6.0% after raising 522 million pounds ($655 million) in a discounted share sale, while Carnival Corp (L:CCL) slipped 1.1% after it reported a quarterly net loss of $4.4 billion.
Prudential (L:PRU) jumped 2.7% after it sold a minority stake in its U.S. business, Jackson, to Apollo Global-backed Athene Holding (N:ATH) for $500 million.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.